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Innate immunity serves as the first line of defense against infectious agents such as
intracellular bacteria. The innate immune platform includes Toll-like receptors (TLRs),
retinoid acid-inducible gene-I-like receptors and other cytosolic nucleic acid sensors,
nucleotide-binding and oligomerization domain-like receptors, adaptors, kinases and other
signaling molecules that are required to elicit effective responses against different
pathogens. Our research group has been using the Gram-negative bacteria Brucella
abortus as a model of pathogen. We have demonstrated that B. abortus triggers MAPK
and NF-κB signaling pathways in macrophages in a MyD88 and IRAK-4-dependent manner.
Furthermore, we claimed that so far TLR9 is the most important single TLR during Brucella
infection. The identification of host receptors that recognize pathogen-derived nucleic
acids has revealed an essential role for nucleic acid sensing in the triggering of immunity
to intracellular pathogens. Besides TLRs, herein we describe recent advances in NOD1,
NOD2, and type I IFN receptors in innate immune pathways during B. abortus infection.
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INTRODUCTION
The immune system traditionally has been divided into innate
and adaptive that act in an integrated manner to elicit an effec-
tive host resistance. The adaptive immune system is slower to
develop a response against pathogens when compared to the
innate immunity. It responds to specific antigens and generates
immunological memory. On the contrary, the innate immune
response is rapid and functions as the first line of defense against
pathogens. Besides the physical barriers at the surface of the body
and the soluble factors, such as complement proteins, it consists
mainly of diverse cellular components including macrophages,
dendritic cells (DCs), granulocytes (basophils, eosinophils, and
neutrophils), and natural killer cells (Dranoff, 2004).
Pathogens regularly display a molecular signature known as
pathogens-associated molecular patterns (PAMPs). The most
common PAMPs are lipopolysaccharide (LPS), peptidogly-
can (PGN), bacterial lipoproteins, flagellin, and nucleic acids
derived from viruses, bacteria, fungi, and protozoa. The host
innate immune system can interact with these PAMPs using a
broad range of germ-line encoded pattern-recognition receptors
(PRRs). PRRs comprise the membrane-bound Toll-like receptors
(TLRs), which are located either at the cytoplasmic membrane
or at the membranes encompassing endosomal vesicles, and
sense molecules in the extracellular compartments and endoso-
mal lumen, respectively (Kumar et al., 2011). However, other
PRRs can interact with cytosolic stimuli and play an addi-
tional role in host-surveillance. The cytosolic RNA-sensing RNA
helicases retinoic acid-inducible gene I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5) (Yoneyama et al.,
2005); the cytosolic DNA sensors, absent in melanoma 2 (AIM2)
and DNA-dependent activator of IRFs (DAI) (Takaoka et al.,
2007; Hornung et al., 2009); as well as the nucleotide bind-
ing and oligomerization domain (NOD)-like receptors (NLRs)
are included in this panoply of intracellular PRRs that recog-
nizes PAMPs and host-derived danger signals (danger-associated
molecular patterns, DAMPs) (Schroder and Tschopp, 2010).
Usually, the innate immune cells drive a response against
pathogens by sensingmolecular stimuli that activate multiple cas-
cades culminating in the expression of an array of genes. Typically,
an intact microbial pathogen displays a set of PAMPs that acti-
vate multiple PRRs in host cells. This is considered the first
step in the activation of multiple intracellular signaling pathways.
Hence, signal transduction initiated after the interaction between
a PAMP with a specific PRR generally results in the activation of
transcription factors. The translocation of activated transcription
factors to the cell nucleus ultimately leads to the expression of
inflammatory cytokines, type I interferon (IFN), chemokines and
other compounds responsible to generate an efficient response
against an infection (Bonizzi and Karin, 2004).
The genus Brucella is composed of facultative intracellu-
lar Gram-negative bacteria that cause brucellosis, a systemic
infectious zoonotic disease characterized, among others symp-
toms, by undulant fever in humans. It was first identified by
Sir David Bruce in the 1860s in Malta, which became known
as Malta fever (Araj, 2010). The species of Brucella are classi-
fied according to their preference for specific animal hosts. For
instance, the bacterium B. abortus naturally infects and causes
abortion in cattle, being responsible for severe economical loss
(Pappas, 2010). The contacts with infected cattle as well as
the consumption of unpasteurized milk from this source are
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important routes for the transmission of B. abortus to humans
(Godfroid et al., 2011).
The strategy of B. abortus is to evade the innate immune
system and persist in the host long enough to be transmitted.
The bacterium contains an unusual lipid A composing the LPS
molecule, which is important for evading the host immune sys-
tem during the early stages of infection (Parent et al., 2007). In
addition, when entering the host intracellular space, B. abortus
displays several strategies to avoid the cellular killing mechanism.
One of the main virulent factors involved in such action is the
Type IV secretion system (T4SS) which is encoded by the virB
operon (de Jong and Tsolis, 2012). After B. abortus is phagocy-
tized, T4SS is induced during phagosomal acidification, leading
to the translocation of effector proteins into host cytosol. This
process is essential for bacteria subvert lysosome fusion and to
create Brucella-containing vacuole (BCV), an organelle permis-
sive for replication that interacts with the endoplasmic reticulum
(ER) (Celli et al., 2003).
Another strategy employed by B. abortus to survive and repli-
cate within macrophages involves host cell death. The attenuated
rough B. abortus strain RB51 lacks the O-antigen of LPS while
the virulent smooth strain S2308 contains the O-antigen por-
tion. It was shown that although RB51 strain induces caspase-
2-dependent apoptosis in macrophages, its parental strain 2308
inhibited this programmed cell death mechanism (Chen and He,
2009). Moreover, the apoptosis promoted by rough strains in
macrophages was correlated with activation of the NF-κB path-
way and production of inflammatory cytokines such as TNF-α
(Chen et al., 2011). Interestingly, both S2308 and RB51 induce
caspase-2-dependent apoptosis in DC albeit more cell death is
promoted by S2308. Taken together, S2308 infection promotes
DC apoptosis reducing DC maturation and S2308 antigens pre-
sentation to T cells. In addition, the virulent Brucella inhibits
macrophage cell death avoiding the exposure to the more hostile
extracellular environment propitiating the survival and replica-
tion inside this cell. In such scenario, the induction of DC cell
death and inhibition of macrophage apoptosis might contribute
to Brucella pathogenesis (Li and He, 2012).
Although the stealthy strategy employed by B. abortus attempt
to create a propitious environment for its replication, host cells
are equipped with molecules that interact direct or indirect with
this bacterium in order to control the infection. Herein, we
will review the prominent findings that have contributed to our
understanding of the molecular mechanisms underlying innate
immune cell recognition and response to B. abortus infection
(Figure 1).
TLR SIGNALING AND ITS ROLE DURING Brucella abortus
INFECTION
The TLR family was originally identified in Drosophila, where
it triggers essential developmental and immunological signal-
ing (Hashimoto et al., 1988). These PRRs were later extensively
characterized and their role in innate immunity well estab-
lished. Currently, 12 members of the TLR family have been
identified in mammals being 10 TLRs in humans (TLR1–10).
TLR11–13, although less characterized, have been identified in
mice, while TLR10 is not expressed in these animals (Kumar et al.,
2011). TLRs are type I transmembrane proteins containing three
domains: an extracellular domain containing leucine-rich repeats
(LRR), which binds PAMPs; a transmembrane domain, spanning
the cytoplasmic or endosomal membranes; and an intracellular
Toll-Interleukin (IL)-1 receptor (TIR) domain, which interacts
with downstream adapter proteins. A common feature of TLRs
is to form homo- or heterodimers upon interaction with PAMPs
(Kondo et al., 2012).
Based on the cellular localization, TLRs can be divided into
two groups. The first group comprises members of TLR family
expressed on the cell surface, such as TLR2 which forms het-
erodimers with TLR1 or TLR6, recognizing bacterial lipopeptides
(Kang et al., 2009). Other members that are expressed on cell sur-
face are TLR4 and TLR5, which interacts with bacterial LPS and
flagellin, respectively. TLR4 requires the adaptor molecule MD-2
to recognize its ligand. Indeed, MD-2 interacting with TLR4
molecule provides the major LPS binding site, inducing homod-
imerization of the TLR4–MD-2 complex (Park et al., 2009).
Similar to TLR4, upon interaction with its cognate ligand, TLR5
also forms a dimer (Yoon et al., 2012). The second group of TLRs
resides in intracellular compartments, with the LRR domains fac-
ing organelle lumens and interacting with nucleic acids derived
from viral or bacterial pathogens. This group includes TLR3, that
recognizes double stranded RNA (dsRNA); TLR7–8, that inter-
acts with single stranded RNA (ssRNA) and TLR9, which binds
unmethylated CpG DNA (Chaturvedi and Pierce, 2009; Blasius
and Beutler, 2010). Initially, these TLRs are located at ER where
they physically interact with UNC93B1. This molecule medi-
ates the translocation of the nucleotide-sensing TLRs from the
ER to the endolysosomal compartment, allowing their proper
activation by microbial RNA and DNA (Kim et al., 2008).
Activation by PAMPs induces TLRs dimerization which brings
the intracellular TIR domains close enough to favor the recruit-
ment of TIR adaptors. This interaction initiates cell signaling
leading to transcription factors activation (Zhu and Mohan,
2010; Kawai and Akira, 2011). All TLRs, except TLR3, use the
myeloid differentiation factor-88 (MyD88) as adaptor. TLR1,
TLR2, TLR4, and TLR6 recruit the TIR domain containing
adaptor protein (TIRAP), which acts as a bridge between TLR
and MyD88. Activation of TLR3 and TLR4 recruits the TIR
domain-containing adapter-inducing IFN-β (TRIF), and TLR4
also requires the adaptor TRIF-related adapter molecule (TRAM)
(Kenny and O’Neill, 2008). The recruitment of MyD88 after
TLR dimerization is followed by the IL-1 receptor-associated
kinase (IRAK) family activation. The IRAKs then recruit the
ubiquitin ligase TNF receptor associated (TRAF6) which, in
turn, activates TGF-beta-associated kinase 1 (TAK1) (Sorrentino
et al., 2008). The TAK1 protein phosphorylates and activates
IκB kinase complex (IKK) (Fraczek et al., 2008) and mito-
gen activated protein kinases (MAPKs), resulting in activation
of nuclear factor (NF)-κB (Bhoj and Chen, 2009) and AP-1
(Cargnello and Roux, 2011) transcription factors, respectively.
Besides the induction of inflammatory cytokines secretion pro-
moted by TLR7 and TLR9 through NF-κB activation, alterna-
tively these receptors elicit the production of type I IFNs by
activating the IFN regulatory factor-7 (IRF-7) (Barber, 2011).
Activation of TLR3 involves two distinct pathways initiated by
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FIGURE 1 | Overview of innate immune signals during B. abortus
infection. B. abortus-associated molecular patterns are recognized by
pattern-recognition receptors. TLR2 is activated by lipidated outer membrane
proteins (L-Omp16 and L-Omp19); TLR4 is activated by B. abortus LPS and
unlipidated outer membrane protein-16 (U-Omp16); and TLR9 is activated by
B. abortus DNA. TLR activation leads to intracellular signaling via MyD88
and IRAK-4 resulting in the activation of NF-κB and MAPKs producing
inflammatory cytokines. Cytosolic sensors are also involved in B. abortus
DNA recognition. This pathway involves an unknown receptor leading to
IFN-β production dependent on STING and IRF3 activation. Autocrine
signaling through the IFN I receptor (IFNAR) leads to activation of signal
transducers JAK and STAT1 which culminates in the transcriptional induction
of genes that carry promoters with IFN-stimulated response elements (ISRE).
Other cytosolic receptors such as NOD1 and NOD2 play an additional role in
recognizing B. abortus. Activation of these receptors by Brucella culminates
in NF-κB activation resulting in cytokines synthesis. Solid arrows represent
the TLR and non-TLR signaling pathways involving MyD88/IRAK-4 axis
important to control B. abortus infection. Discontinuous arrows represent
TLR, NOD1, NOD2, and type I IFN receptor signaling that are not necessary
for B. abortus clearance.
the adaptor TRIF. TRIF recruits TRAF6 resulting in activa-
tion of the NF-κB and inflammatory cytokines expression as
described above. Alternatively, TRIF binds TANK-binding kinase
1 (TBK-1) activating IRF-3 promotion IFN-β expression (Sato
et al., 2003). TLR4 is unique as it recruits four distinct adap-
tors. The MyD88-dependent pathway involves TIRAP leading
to an early-phase activation of NF-κB and AP-1. The MyD88-
independent pathway requires the endocytosis of TLR4, which
is transported to intracellular vesicles, where it forms a complex
with TRAM and TRIF. TRIF then recruits TRAF6 which, in turn,
activates TAK1, initiating the late-phase activation of NF-κB and
AP-1. TRIF also initiates the signaling cascade to activate IRF-3
through TRAF3 and TBK-1, leading to type I IFN expression
(Kawai and Akira, 2011).
Based on the cell signaling initiated upon TLRs activation,
it is evident that the protein MyD88 plays a pivotal role in the
innate immune response against several pathogens. In fact, it was
shown that MyD88−/− mice are inefficient to control B. abortus
infection and the production of inflammatory cytokines by
macrophages is completely abrogated (Weiss et al., 2005). The
susceptibility of MyD88−/− mice to B. abortus infection was fur-
ther correlated to impaired DC maturation and lack of IL-12
synthesis by our group (Macedo et al., 2008). Moreover, DC
activation during infection stimulates T cells to produce IFN-γ,
which plays an essential role controlling B. abortus infection
(Brandão et al., 2012). IRAK-4, another central protein mediating
cell signaling upon TLR activation, was correlated with efficient
clearance of B. abortus in mice, but not at later phases of infec-
tion. Similar to MyD88−/−, macrophages and DC derived from
IRAK4−/− mice are unable to produce inflammatory cytokines
in response to B. abortus (Oliveira et al., 2011). The central role
attributed to MyD88 and IRAK-4 proteins might suggest the
participation of TLRs during the control of B. abortus infec-
tion. Initially, it was shown that TLR2 plays no role in con-
trolling B. abortus infection in mice. Regarding TLR4, there
are some controversies in the field. The production of TNF-α
by macrophages derived from TLR2−/− and TLR4−/− mice
is reduced in B. abortus infection. Furthermore, it was shown
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that the B. abortus noncanonical LPS does not display a potent
immunostimulatory activity (Weiss et al., 2005). Additionally, it
was described a TLR4-dependent production of inflammatory
cytokines induced by the unlipidated outer membrane protein
(OMP) 16 (U-OMP16) derived from B. abortus (Pasquevich
et al., 2010). In addition, murine peritoneal macrophages pro-
duce TNF-α and IL-6 through TLR2 activation upon infection
with B. abortus or when stimulated with its lipoprotein L-Omp-19
(Delpino et al., 2012). This result confirms the idea that lipopro-
teins instead LPS are the main mediators of the inflammatory
response elicited by B. abortus (Giambartolomei et al., 2004).
Thus, TLR2 recognizes B. abortus components inducing inflam-
matory cytokines production. However, this receptor plays no
role in mice resistance to B. abortus infection in vivo. Moreover,
TLR9 was correlated with proper B. abortus infection control
in mice, at least in early stages of infection (at two weeks).
Additionally, the production of inflammatory cytokines by DC
and macrophages derived from TLR9−/− mice are partially
reduced upon stimulation with heat-killed B. abortus (HKBa)
(Macedo et al., 2008).
The production of immune mediators upon TLR activation
depends on intracellular signaling of MAPKs, which include
the extracellular signal-regulated kinases 1 and 2 (ERK1/2),
c-Jun amino-terminal kinases (JNK) and p38 (Cargnello and
Roux, 2011). Previously, it was shown that B. abortus rough
mutant RB51 and smooth wild type S2308 strain induce phos-
phorylation of ERK1/2 and p38. However, the activation of
these MAPKs is more prominent when the rough strain was
used as stimulus (Jiménez De Bagüés et al., 2005). Moreover,
our group showed that ERK1/2 and p38 as well as p65 NF-
κB phosphorylation is profoundly impaired in IRAK-4−/−
and MyD88−/− macrophages activated by B. abortus (Oliveira
et al., 2011). Clearly, the requirement of MyD88 and IRAK-4
in MAPKs activation argues to the participation of TLRs
in cell signaling upon B. abortus infection. Indeed, it was
shown that HKBa triggers ERK1/2 and p38 phosphorylation
through activation of TLR2 in DCs. In that case, p38 but not
ERK1/2 activation is correlated with HKBa phagocytosis and
IL-12 production (Zhang et al., 2012). Taken together, these
findings suggest that B. abortus might activate several innate
receptors culminating in cell signaling activation and cytokine
production.
NOD LIKE-RECEPTORS (NLRs): NOD1, NOD2, AND
INFLAMMASOMES
The NLRs are intracellular molecules that play a critical role
in the innate immune system providing surveillance by rec-
ognizing structures carried by microbial components at the
cytosol (Shaw et al., 2008). NLRs are expressed in immune
and non-immune cells such as epithelial and mesothelial cells.
There are 23 NLR family members in humans and at least
34 genes in mice (Franchi et al., 2009b). NLRs contain a
nucleotide-binding domain (NBD) and a LRR domain. The
NBD binds nucleotides inducing conformational changes that
are essential to NLRs functions. The LRR domain is required
to sense different microbial and endogenous damage stim-
uli (PAMPs and DAMPs) (Elinav et al., 2011; Franchi et al.,
2012). The NLRs display other additional domains that include
an amino (N)-terminal caspase recruitment domain (CARD),
pyrin domain and acidic transactivating domain or baculovirus
inhibitor repeat that mediates downstream protein–protein inter-
action (Franchi et al., 2012).
The first identified NLRs, NOD1, and NOD2, recognize
cell wall fragments from Gram-negative and Gram-positive
bacteria. NOD1 senses a specific PGN fragment containing
diaminopimelic acid (DAP) that is produced by most Gram-
negative and certain Gram-positive bacteria (Chamaillard et al.,
2003); while NOD2 is activated by muramyl dipeptide (MDP),
which is a conserved structure in practically all types of PGN
(Pauleau and Murray, 2003). Following stimulation by their spe-
cific bacterial molecules such as DAP or MDP, NOD1, and NOD2
associate with an adaptor molecule, RIP2, through CARD–CARD
interaction, which leads to activation of NF-κB and MAPKs pro-
moting induction of numerous genes involved in inflammatory
process (Kobayashi et al., 2002; Abbott et al., 2004).
Recent studies described the importance of NOD1 and/or
NOD2 signaling in host defense against microbial pathogens
such as Salmonella enterica (Keestra et al., 2011), Helicobacter
pylori (Viala et al., 2004), Listeria monocytogenes (Kobayashi et al.,
2005), Staphylococcus aureus (Hruz et al., 2009), and Legionella
pneumophila (Frutuoso et al., 2010). Although macrophages
derived from NOD2-deficient mice were impaired in the produc-
tion of inflammatory cytokines upon Mycobacterium tuberculosis
infection, this receptor plays no role controlling the replication of
M. tuberculosis infection in vivo (Gandotra et al., 2007).
Inflammasomes are multiprotein complexes that activate
caspase-1 which leads to maturation of the inflammatory
cytokines IL-1β and IL-18 and the induction of pyroptosis
(Franchi et al., 2009a; Miao et al., 2011). The activation and
release of IL-1β and IL-18 requires two signals: the first signal
involves the production of inactive precursors (pro-IL-1β and
pro-IL-18) and the second signal results in the assembly of the
inflammasome and activation of caspase-1 (which might require
the adaptor ASC). The activation of caspase-1 is also involved in
the induction of pyroptosis, autophagy and pathogen degrada-
tion through unidentifiedmechanisms (Fernandes-Alnemri et al.,
2007; Schroder and Tschopp, 2010).
Four major inflammasomes have been identified, three of
which belong to NLR family, named after the receptor that reg-
ulates their activity: NLR family, pyrin domain-containing 1B
(NLRP1B); NLR family, pyrin domain-containing 3 (NLRP3);
NLR family, CARD-containing 4 (NLRC4); and AIM2, a recep-
tor of the HIN family of protein (Franchi et al., 2012). Each
inflammasome is assembled in a stimulus-specific manner to
cluster molecules of pro-caspase-1. For instance, the NLRP1
inflammasome is activated by anthrax lethal toxin and there
is some evidence that NLRP1 may detect PGN (Boyden and
Dietrich, 2006; Faustin et al., 2007). As for NLRP3, this receptor
is activated by a broad range of stimuli, including pathogen-
derived signals (bacterial and viral RNA, pore-forming toxins),
environment-derived factors (silica, asbestos, alum), and DAMPs
(ROS, ATP, uric acid, hyaluronan, amyloid-β) (Kanneganti
et al., 2006; Mariathasan et al., 2006; Petrilli et al., 2007;
Halle et al., 2008; Hornung et al., 2008; Allen et al., 2009;
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Martinon et al., 2009; Yamasaki et al., 2009; Eigenbrod et al.,
2012). Regarding NLRC4, it senses flagellin or the basal body
rod component of the type 3 secretion system found in some
bacteria (Miao et al., 2010). The AIM2 inflammasome is a
receptor for cytosolic DNA which promotes caspase-1 activa-
tion (Hornung et al., 2009; Rathinam et al., 2010). Pyroptosis
and production of IL-1β and IL-18 mediated by inflamma-
somes have been shown to be protective against many infec-
tious agents, including Gram-positive (e.g., Staphylococcus and
Listeria) and Gram-negative (e.g., Salmonella, Legionella, and
Pseudomonas) bacteria (Mariathasan et al., 2004, 2006; Lamkanfi
andDixit, 2009; Arlehamn and Evans, 2011; Massis and Zamboni,
2011).
Our group was the first to report the role of the NLRs such
as NOD1 and NOD2 during B. abortus infection in mice. It
was observed a reduced production of TNF-α in bone-marrow
derived macrophages from NOD1−/−, NOD2−/− and RIP2−/−
mice compared to wild-type animals. However, NOD1-, NOD2-,
and RIP2-deficient animals showed the same bacterial load in
spleens compared to wild-type mice. These results suggest that
these molecules may contribute to signal in response to B. abortus
but they are not essential for host defense against this infection
in vivo (Oliveira et al., 2012).
TYPE I INTERFERON SIGNALING AND ITS ROLE DURING
Brucella abortus INFECTION
Classically, exposure of cells to type I IFN induces an antivi-
ral state that prevents productive viral infection. This premise
was postulated by Isaacs and Lindenmann about 60 years ago
when they demonstrated the cell ability to resist a virus infec-
tion. This phenomenonwas then attributed to type I IFN cytokine
considered the factor responsible to interfere in the viral infec-
tion (Isaacs and Lindenmann, 1957). Type I IFN is represented
by several partially homologous genes of IFN-α and a single
gene of IFN-β and those genes can be expressed by almost any
type of cell in response to stimulation of an array of recep-
tors by pathogens (Decker et al., 2005). The most common
and prevalent way by which type I IFN is induced is based on
innate immune recognition of PAMPs in cell cytosol. The RIG-I
and MDA5 are cytoplasmic receptors responsible for triggering
type I IFN secretion after foreign dsRNA recognition transmitting
intracellular signaling mediated by the mitochondria-localized
adaptor molecule IPS-1 (also known as MAVS) and the kinases
TBK1 and IKKi to activate IRF3, the main transcription acti-
vator of IFN-β gene. Cytosolic DNA sensors such as DAI or
Z-DNA binding protein 1 are included in other group of innate
immune receptors able to induce type I IFN (Takaoka et al.,
2007). However, it was demonstrated that DAI is not the only
DNA sensor that activates type I IFN production suggesting a
redundant pathway of DNA recognition able to induce IFN. Yang
and collaborators (2010) showed that a protein called LRRFIP1
was also able to recognize Listeria monocytogenes dsDNA using
β-catenin as transcriptional co-activator of IFN-β gene. Chiu
and colleagues (2009) suggested another intracellular way to rec-
ognize foreign DNA. They proposed a mechanism of dsDNA
sensing which depends on the ability of cytosolic B-DNA be
transcribed into 5′-ppp RNA by RNA-polymerase III, which
then activates type I IFN transcription through RIG-I (Chiu
et al., 2009). Besides nucleic acid-sensing immune machinery
described, TLRs are also considered innate immune receptors
able to induce type I IFN in some cells, as described before.
For instance, group B streptococcus has been shown to induce
type I IFN by conventional DCs via TLR7, MyD88, and IRF1
(Mancuso et al., 2009).
The IFN-β stimulates a classical Janus kinases (Jak1) intra-
cellular pathway through a two subunits receptor called IFN I
receptor (IFNAR) (Brierley and Fish, 2002). The subsequent sig-
naling leads to activation of signal transducers (STAT1, STAT2,
and IRF9) which culminates in the transcriptional induction of
genes that carry promoters with IFN-stimulated response ele-
ments (ISRE) such as IRF7. The newly synthesized IRF7 translo-
cated to the nucleus when activated binding to IFNα/β promoters.
In an autocrine and/or paracrine way, IFN-α or IFN-β can act
through binding to IFNAR and restart the signaling amplify-
ing the effects of type I IFN (Honda and Taniguchi, 2006).
Besides, IFNAR signaling also activates transcriptionally other
genes with different action in the cell such as pro-apoptotic
genes, chemokines and PKR (dsRNA dependent protein kinase).
Regarding that, type I IFN are more than just anti-viral as
they play a major role in linking innate to adaptive immunity
(Nagarajan et al., 2011).
Besides virus, an increase number of pathogens have been
reported to be inducers of type I IFN as bacteria, protozoa, or
fungi (Meissner et al., 2005; Monroe et al., 2010; Haque et al.,
2011; Sharma et al., 2011; Vivarini Ade et al., 2011). During
bacterial infections, type I IFN is often produced, but its effects
are conflicting and do not always favoring the immune response
of the host against the infection. Type I IFN related to pre-
vent bacterial infection was first demonstrated for pathogens
from Chlamydia genus (de La Maza et al., 1985). Type I IFN
is able to kill the bacteria and inhibit chronic infection due the
cytokine effects in blocking the production of infectious organ-
isms since this effect is reversed by exogenous tryptophan and
iron which are essential elements for Chlamydia growth (Ishihara
et al., 2005). The limitation of bacterial infection by type I IFN
induction was also observed in the case of C. pneumoniae and
Legionella pneumophila (Plumlee et al., 2009; Buss et al., 2010).
The control of C. pneumoniae infection in human endothelial
cells was dependent of endogenous IFN-β via intracellular sig-
naling dependent of MAVS, IRF3, and IRF7 (Buss et al., 2010).
In the case of L. pneumophila, the autocrine type I IFN signal-
ing mediated by IFNAR, in a pathway independent of STAT1, -2,
and -3, is responsible for bacterial control in the host (Plumlee
et al., 2009). Also, type I IFN protects mice against Salmonella
typhimurium infection due the activation of IFN-γ via STAT4
independent of IL-12 (Freudenberg et al., 2002). Other important
group of bacteria that activates IFN I after cellular recogni-
tion is group A streptococcus in a intracellular pathway that
requires MyD88 but is independent of the TLR2, TLR4, and
TLR9 (Gratz et al., 2008). On the other hand, there are a vari-
ety of bacteria that are recognized by the innate immune system
inducing type I IFN but developing a detrimental phenotype to
the host. Francisella tularensis and Listeria monocytogenes induce
type I IFN during infection and it was demonstrated that the
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signaling mediated by IFNAR is harmful to host since knockout
mice for this receptor are more resistant to those infections
(Fehr et al., 1997; Auerbuch et al., 2004; Carrero et al., 2004;
Stockinger and Decker, 2008; O’Connor et al., 2009; Henry et al.,
2010). There are several mechanisms behind type I IFN induc-
tion leading to adverse phenotype during bacterial infection.
The augmentation of pro-apoptotic stimulus in macrophages and
lymphocytes was described in infection with Listeria, Bacillus
anthracis, Mycobacteria, and Chlamydia spp and suggested to
be related to detrimental phenotype to the host (Carrero et al.,
2004; Gold et al., 2004; O’Connell et al., 2004; Decker et al.,
2005; Qiu et al., 2008). Even though the pro-apoptotic effects of
type I IFN are not fully known, in L. monocytogenes infection,
type I IFN facilitates the Listeriolysin O-induced lysis of lym-
phocytes and macrophages facilitating bacteria spread (Carrero
et al., 2004, 2006). Type I IFN also is involved in up-regulation
of pro-apoptotic innate sensors, such as TLRs and the inflam-
masomes (Trinchieri, 2010). For instance, type I IFN induced
by Francisella spp infection augments the expression of AIM2
resulting in caspase-1 activation and in the production of IL-1β
and IL-18 as well as inflammasome-mediated cell death in
response to cytosolic dsDNA (Choubey et al., 2010; Fernandes-
Alnemri et al., 2010). Also, IFN I induced during F. tularensis
and L. monocytogenes infections limits secretion of IL-17 by T
cells and limits effective Th1 immune responses to M. tubercu-
losis in part by inducing negative regulator molecules such as
suppressor of cytokine signaling proteins (Manca et al., 2005;
Henry et al., 2010).
The first observation that Brucella induces type I IFN was
made by Huang and colleagues (2005) when IFN-α was detected
in serum of wild type mice injected with HKBa and the level
was markedly reduced in the TLR9−/− mice serum, demonstrat-
ing that HKBa induces IFN-α in a TLR9-dependent manner.
Additionally, it has shown that B. abortus is able to induce IFN-β
in DCs (Salcedo et al., 2008). Our group has revealed recently
an interesting role of type I IFN during B. abortus infection
(de Almeida et al., 2011). The absence of type I IFN signaling
enhanced host protection to B. abortus infection since IFNAR−/−
showed to be more resistant to infection than wild type mice.
Additionally the spleen derived from Brucella-infected IFNAR−/−
mice exhibited a drastic reduction in splenic apoptosis com-
pared to wild type controls similar to L. monocytogenes results
presented by Carrero et al. (2006). Mice lacking IFNAR were
more resistant to B. abortus infection and displayed less apop-
totic lesions as well as reduced expression of pro-apoptotic gene
TRAIL than their wild type counterparts speculating that type I
IFN signaling enhances immune cells apoptosis; therefore, caus-
ing the increased susceptibility to B. abortus. Furthermore, we
demonstrated that B. abortus DNA is a major bacterial compo-
nent to induce IFN-β in macrophages occurring mostly indepen-
dent of TLRs. Surprisingly, type I IFN expression by B. abortus
or its DNA was dependent on MyD88, a intracellular pathway
observed in Streptococcus and Bacillus anthracis infection medi-
ated by an unknown PRR (Glomski et al., 2007; Gratz et al.,
2008; de Almeida et al., 2011). On the other hand, we demon-
strated that the adaptor molecule TRIF played no role in type I
IFN induction or in vivo host control of B. abortus. In addition,
we and other groups are intensively searching for cytosolic recep-
tors which are capable of sensing pathogen nucleic acids released
from lysed bacteria or from bacterial secretion system during
infection (Monroe et al., 2010). Regarding that, we analyzed
the potential role of RNA polymerase III in detecting segments
of B. abortus DNA transcribing them into RNA that induce
IFN-β possibly through the RIG-I pathway. Using a inhibitor of
RNA polymerase III (ML-60218) (Chiu et al., 2009), we sug-
gested that this enzyme plays a key role in sensing bacterial
DNA during B. abortus infection triggering intracellular acti-
vation of type I IFN. Additionally, the type I IFN induction
promoted by B. abortus DNA was mediated by an ER resident
transmembrane protein termed stimulator of IFN genes (STING)
(de Almeida et al., 2011). STING was also identified as essen-
tial for type I IFN production in response to L. monocytogenes
and C. muridarum (Ishikawa and Barber, 2008; Prantner et al.,
2010). In addition, type I IFN produced in response to B. abor-
tus or its DNA signals in an autocrine manner leading to the
Tyr701 phosphorylation-dependent activation of STAT1 through
IFNAR (de Almeida et al., 2011). In summary, our group has
been dissecting host innate response pathways using B. abortus
as a model of infection. The induction of type I IFN by this
bacterium opens up a new avenue to study intracellular path-
ways induced by pathogens as a way to evade from host immune
system.
FUTURE PERSPECTIVES
The past decade has witnessed great advances in our under-
standing of molecular mechanisms underlying innate immune
system activation. Structural analysis of several TLRs have elu-
cidated the mechanisms of PAMP recognition by TLR homo-
or heterodimers, and many signaling molecules involved in the
activation of NF-kB, AP-1, and IRF proteins have been identi-
fied and characterized in detail. Regarding B. abortus infection,
the TLR9 has been suggested so far as the most important
single TLR to activate the host immune system. The identifica-
tion of host receptors that recognize pathogen-derived nucleic
acids has revealed an essential role for nucleic acid sensing
in the triggering of immunity to intracellular pathogens. Our
research group is currently identifying Brucella DNA motifs
involved in activation of the host innate immune system. Nucleic
acids act as adjuvants to activate innate immune programs
via TLRs and/or other PRRs and have key roles in facilitat-
ing adaptive immunity to intracellular pathogens. Therefore,
the use of PAMPs and/or endogenous agonists that stimulate
immune cells will be critical for design new effective vac-
cines. Moreover, during a mammalian infection, B. abortus must
establish a replicative niche in the presence of a robust innate
immune system. The inflammasome is of critical importance
to mount an effective innate immune response against intracel-
lular pathogens. Investigation into the interaction of B. abor-
tus and the inflammasomes might place a new perspective of
sensing bacterial components. A better understanding of the
mechanisms underlying Brucella interaction with inflamma-
somes may reveal important findings regarding IL-1β production
and its association with the clinical symptoms of intermittent
undulant fever, a hallmark of human patients with brucellosis.
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Understanding the complexity of the transcriptional networks
that operate during innate immune receptors activation and
define the subsequent immune responses and pathological man-
ifestations during B. abortus infection is the major focus of our
research.
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